Abstract
We evaluated the interaction of antiphospholipid antibodies (aPL) with placental anticoagulant protein I (PAP I), a calcium-dependent phospholipid binding protein which may act as a natural anticoagulant. Clotting assays showed additive prolongation of clotting times with aPL and PAP I. ELISA and vesicle phospholipid binding studies showed PAP I inhibition of aPL binding to phospholipid but no inhibition of PAP I-phospholipid binding by aPL. aPL and PAP I interact additively in anticoagulant activity in in vitro clotting systems and compete for phospholipid in ELISA system. These data support the hypotheses that aPL and PAP I may recognize similar phospholipid epitopes and that in vivo interaction may occur. © 1992 Plenum Publishing Corporation.
Author supplied keywords
Cite
CITATION STYLE
Sammaritano, L. R., Gharavi, A. E., Soberano, C., Levy, R. A., & Lockshin, M. D. (1992). Phospholipid binding of antiphospholipid antibodies and placental anticoagulant protein. Journal of Clinical Immunology, 12(1), 27–35. https://doi.org/10.1007/BF00918270
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.